A detailed history of Cibc World Markets Corp transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Cibc World Markets Corp holds 26,554 shares of ACAD stock, worth $592,154. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,554
Previous 11,199 137.11%
Holding current value
$592,154
Previous $205,000 115.12%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025

BUY
$16.61 - $20.29 $255,046 - $311,552
15,355 Added 137.11%
26,554 $441,000
Q4 2024

Feb 10, 2025

BUY
$14.29 - $18.76 $160,033 - $210,093
11,199 New
11,199 $205,000

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $3.61B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Cibc World Markets Corp Portfolio

Follow Cibc World Markets Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Markets Corp, based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Markets Corp with notifications on news.